FDA Committees to Discuss Female Sex Health
When a Child is Intersex
Two committees of the U.S. Food and Drug Administration (FDA) will meet on June 4th to discuss flibanserin, a drug designed to treat low libido in women.
The drug has been submitted for FDA approval twice before, but has been denied each time because of safety concerns. The FDA also questions how effective the drug is.
Developed by Sprout Pharmaceuticals, flibanserin is intended for premenopausal women with hypoactive sexual desire disorder (HSDD). This condition is marked by a chronic lack of interest in sex accompanied by emotional distress.
More details on this week's meeting are available here.
Intersex conditions occur when a fetus develops differently from a typical male or female. Boys may be born without a penis, girls without a fully developed vagina. Sometimes, intersex babies have both male and female characteristics.
Parenting an intersex child has some challenges. In our latest blog post, we discuss different types of intersex conditions, how they happen, and points to consider for children and for families. We also provide some links for further information.
Click here for more details.